Copper-Mediated Late-Stage Functionalization of Heterocycle-Containing Molecules

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Catalysis

Background:

• Directed C-H functionalization is crucial for drug discovery.
• Heterocyclic substrates often poison transition-metal catalysts due to nitrogen/sulfur atom coordination.
• This competitive binding limits C-H functionalization applications in late-stage drug development.

Purpose of the Study:

• To develop a directing group that overcomes catalyst poisoning by heterocycles.
• To enable late-stage functionalization of complex heterocyclic drug molecules.
• To demonstrate the utility of this new directing group in pharmaceutical research.

Main Methods:

• Utilized an oxazoline-based directing group for C-H functionalization.
• Employed copper-mediated reactions for C-H amination, hydroxylation, thiolation, arylation, and trifluoromethylation.
• Applied the method to the diversification of Telmisartan, an angiotensin II receptor antagonist.

Main Results:

• The oxazoline directing group successfully overrode catalyst poisoning by various heterocycles.
• Diverse C-H functionalization reactions were achieved on heterocyclic substrates.
• Telmisartan was effectively diversified, showcasing the method's potential in drug discovery.

Conclusions:

• The developed oxazoline directing group is effective in overcoming catalyst poisoning in C-H functionalization of heterocycles.
• This strategy significantly expands the scope of late-stage functionalization for drug discovery.
• The method provides a powerful tool for the rapid diversification of pharmaceutical compounds.